- Filed
- Mar 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 3, 2025 | 172.81M sh |
| Long Term Debt | Q1 2025 · Jan 31, 2025 | $1.79B |
| Long Term Debt | Q1 2025 · Oct 31, 2024 | $1.79B |
| Cash And Equivalents | Q1 2025 · Jan 31, 2025 | $2.06B |
| Cash And Equivalents | Q1 2025 · Oct 31, 2024 | $1.8B |
| Stockholders Equity | Q1 2025 · Jan 31, 2025 | $5.19B |
| Stockholders Equity | Q1 2025 · Oct 31, 2024 | $5.11B |
| Current Liabilities | Q1 2025 · Jan 31, 2025 | $1.51B |
| Current Liabilities | Q1 2025 · Oct 31, 2024 | $1.43B |
| Total Liabilities | Q1 2025 · Jan 31, 2025 | $4.2B |
| Total Liabilities | Q1 2025 · Oct 31, 2024 | $4.16B |
| Current Assets | Q1 2025 · Jan 31, 2025 | $4.46B |
| Current Assets | Q1 2025 · Oct 31, 2024 | $4.26B |
| Total Assets | Q1 2025 · Jan 31, 2025 | $9.39B |
| Total Assets | Q1 2025 · Oct 31, 2024 | $9.27B |
| Shares Diluted | Q1 2025 · Jan 31, 2024 | 176M sh |
| Stock Repurchased | Q1 2025 · Jan 31, 2024 | $93M |
| Capex | Q1 2025 · Jan 31, 2024 | $47M |
| Operating Cash Flow | Q1 2025 · Jan 31, 2024 | $328M |
| Eps Diluted | Q1 2025 · Jan 31, 2024 | $0.98 |
| Eps Basic | Q1 2025 · Jan 31, 2024 | $0.98 |
| Sga Expense | Q1 2025 · Jan 31, 2024 | $362M |
| Rd Expense | Q1 2025 · Jan 31, 2024 | $232M |
| Net Income | Q1 2025 · Jan 31, 2024 | $172M |
| Operating Income | Q1 2025 · Jan 31, 2024 | $221M |